BCL2A1 and ovarian carcinoma: Importantly, the subcellular localization of BCL2A1 to mitochondria further confirmed that BCL2A1 is a crucial regulator of the mitochondria-mediated apoptotic pathway, indicating that it is a potential therapeutic target for the treatment of the peritoneal metastases of ovarian cancer.